Imaging Synucleinopathies

被引：31
作者：
Brooks, David J. [1 ,2 ,3 ]
Tambasco, Nicola [4 ,5 ]
机构：
[1] Aarhus Univ, Inst Clin Med, Dept Nucl Med, Aarhus, Denmark
[2] Imperial Coll London, Dept Med, London, England
[3] Newcastle Univ, Div Neurol, Newcastle Upon Tyne, Tyne & Wear, England
[4] Azienda Osped, Dept Neurol, Perugia, Italy
[5] Univ Perugia, Perugia, Italy
来源：
MOVEMENT DISORDERS | 2016年 / 31卷 / 06期
关键词：
Parkinson's; MRI; PET; SPECT; MSA; DLB; MULTIPLE SYSTEM ATROPHY; PROGRESSIVE SUPRANUCLEAR PALSY; POSITRON-EMISSION-TOMOGRAPHY; F-18 DOPA PET; EARLY PARKINSONS-DISEASE; MAGNETIZATION-TRANSFER; DIFFERENTIAL-DIAGNOSIS; SUBSTANTIA-NIGRA; LEWY BODIES; IN-VIVO;
D O I：
10.1002/mds.26547
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In this review the structural and functional imaging changes associated with the synucleinopathies PD, MSA, and dementias associated with Lewy bodies are reviewed. The role of imaging for supporting differential diagnosis, detecting subclinical disease, and following disease progression is discussed and its potential use for monitoring disease progression is debated. (C) 2016 International Parkinson and Movement Disorder Society
引用
收藏
页码：814 / 829
页数：16
相关论文
共 110 条
  • [1] PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation
    Adams, JR
    van Netten, H
    Schulzer, M
    Mak, E
    Mckenzie, J
    Strongosky, A
    Sossi, V
    Ruth, TJ
    Lee, CS
    Farrer, M
    Gasser, T
    Uitti, RJ
    Calne, DB
    Wszolek, ZK
    Stoessl, AJ
    [J]. BRAIN, 2005, 128 : 2777 - 2785
  • [2] Magnetization transfer ratio in early period of Parkinson disease
    Anik, Yonca
    Iseri, Pervin
    Demirci, Ali
    Komsuoglu, Sezer
    Inan, Nagihan
    [J]. ACADEMIC RADIOLOGY, 2007, 14 (02) : 189 - 192
  • [3] [C-11] RACLOPRIDE AND POSITRON EMISSION TOMOGRAPHY IN PREVIOUSLY UNTREATED PATIENTS WITH PARKINSONS-DISEASE - INFLUENCE OF L-DOPA AND LISURIDE THERAPY ON STRIATAL DOPAMINE D-2-RECEPTORS
    ANTONINI, A
    SCHWARZ, J
    OERTEL, WH
    BEER, HF
    MADEJA, UD
    LEENDERS, KL
    [J]. NEUROLOGY, 1994, 44 (07) : 1325 - 1329
  • [4] Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET
    Antonini, A
    Kazumata, K
    Feigin, A
    Mandel, F
    Dhawan, V
    Margouleff, C
    Eidelberg, D
    [J]. MOVEMENT DISORDERS, 1998, 13 (02) : 268 - 274
  • [5] Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease
    Aquino, Domenico
    Contarino, Valeria
    Albanese, Alberto
    Minati, Ludovico
    Farina, Laura
    Grisoli, Marina
    Elia, Antonio
    Bruzzone, Maria Grazia
    Chiapparini, Luisa
    [J]. NEUROLOGICAL SCIENCES, 2014, 35 (05) : 753 - 758
  • [6] Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: Comparison with non-demented cases and Alzheimer's disease
    Armstrong, RA
    Cairns, NJ
    Lantos, PL
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 (04) : 187 - 192
  • [7] Cognitive Impairment and Resting-State Network Connectivity in Parkinson's Disease
    Baggio, Hugo-Cesar
    Segura, Barbara
    Sala-Llonch, Roser
    Marti, Maria-Jose
    Valldeoriola, Francesc
    Compta, Yaroslau
    Tolosa, Eduardo
    Junque, Carme
    [J]. HUMAN BRAIN MAPPING, 2015, 36 (01) : 199 - 212
  • [8] MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects
    Bartzokis, G
    Cummings, JL
    Markham, CH
    Marmarelis, PZ
    Treciokas, LJ
    Tishler, TA
    Marder, SR
    Mintz, J
    [J]. MAGNETIC RESONANCE IMAGING, 1999, 17 (02) : 213 - 222
  • [9] Benamer HTS, 2000, MOVEMENT DISORD, V15, P503, DOI 10.1002/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO
  • [10] 2-V
12345678910